Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyoshi Morimoto

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 15, 2002
Delusional disorder: molecular genetic evidence for dopamine psychosisKiyoshi Morimoto, Ryosuke Miyatake, Mitsuo Nakamura, et al.
Journal of Clinical Pharmacology|May 3, 2017
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS-3801b, a Motilin Receptor Agonist, in Healthy SubjectsJustin Dennie, George Atiee, Vance Warren, et al.
European Journal of Pharmacology|March 21, 2008
Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responsesHiroshi Tsuchida, Sakiko Takahashi, Emi Nosaka, et al.
European Journal of Pharmacology|August 19, 2008
Novel triple neurokinin receptor antagonist CS-003 inhibits respiratory disease models in guinea pigsHiroshi Tsuchida, Sakiko Takahashi, Emi Nosaka, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 30, 2008
Adenovirus E1A regulates lung epithelial ICAM-1 expression by interacting with transcriptional regulators at its promoterKiyoshi Morimoto, John Gosselink, Aileen Kartono, et al.
Epilepsy Research|September 29, 2004
Quantitative evaluation of central-type benzodiazepine receptors with [(125)I] Iomazenil in experimental epileptogenesis. I. The rat kainate model of temporal lobe epilepsyHiroshi Tamagami, Kiyoshi Morimoto, Takemi Watanabe, et al.
Epilepsy Research|September 29, 2004
Quantitative evaluation of central-type benzodiazepine receptors with [(125)I]Iomazenil in experimental epileptogenesis: II. The rat cortical dysplasia modelKiyoshi Morimoto, Takemi Watanabe, Takashi Ninomiya, et al.
Brain Research|March 17, 2004
Kindling of the ventral tegmental area induces supersensitivity in the central dopamine systemTakemi Watanabe, Kiyoshi Morimoto, Mitsuo Nakamura, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|April 21, 2015
Evaluation of a repeated-dose liver micronucleus assay with 2,6-dinitrotoluene using young adult ratsTadashi Imamura, Akiko Koeda, Kiyoshi Morimoto, et al.
The Journal of Toxicological Sciences|August 2, 2011
Genotoxicity studies of 2,6-dinitrotoluene (2,6-DNT)Hiroshi Suzuki, Tadashi Imamura, Akiko Koeda, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 15, 2002
Delusional disorder: molecular genetic evidence for dopamine psychosisKiyoshi Morimoto, Ryosuke Miyatake, Mitsuo Nakamura, et al.
Journal of Clinical Pharmacology|May 3, 2017
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS-3801b, a Motilin Receptor Agonist, in Healthy SubjectsJustin Dennie, George Atiee, Vance Warren, et al.
European Journal of Pharmacology|March 21, 2008
Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responsesHiroshi Tsuchida, Sakiko Takahashi, Emi Nosaka, et al.
European Journal of Pharmacology|August 19, 2008
Novel triple neurokinin receptor antagonist CS-003 inhibits respiratory disease models in guinea pigsHiroshi Tsuchida, Sakiko Takahashi, Emi Nosaka, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 30, 2008
Adenovirus E1A regulates lung epithelial ICAM-1 expression by interacting with transcriptional regulators at its promoterKiyoshi Morimoto, John Gosselink, Aileen Kartono, et al.
Epilepsy Research|September 29, 2004
Quantitative evaluation of central-type benzodiazepine receptors with [(125)I] Iomazenil in experimental epileptogenesis. I. The rat kainate model of temporal lobe epilepsyHiroshi Tamagami, Kiyoshi Morimoto, Takemi Watanabe, et al.
Epilepsy Research|September 29, 2004
Quantitative evaluation of central-type benzodiazepine receptors with [(125)I]Iomazenil in experimental epileptogenesis: II. The rat cortical dysplasia modelKiyoshi Morimoto, Takemi Watanabe, Takashi Ninomiya, et al.
Brain Research|March 17, 2004
Kindling of the ventral tegmental area induces supersensitivity in the central dopamine systemTakemi Watanabe, Kiyoshi Morimoto, Mitsuo Nakamura, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|April 21, 2015
Evaluation of a repeated-dose liver micronucleus assay with 2,6-dinitrotoluene using young adult ratsTadashi Imamura, Akiko Koeda, Kiyoshi Morimoto, et al.
The Journal of Toxicological Sciences|August 2, 2011
Genotoxicity studies of 2,6-dinitrotoluene (2,6-DNT)Hiroshi Suzuki, Tadashi Imamura, Akiko Koeda, et al.
Pageof 3